Shoichi Hazama

10.9k total citations
187 papers, 4.5k citations indexed

About

Shoichi Hazama is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Shoichi Hazama has authored 187 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 107 papers in Oncology, 54 papers in Molecular Biology and 49 papers in Immunology. Recurrent topics in Shoichi Hazama's work include Cancer Immunotherapy and Biomarkers (34 papers), Immunotherapy and Immune Responses (34 papers) and Colorectal Cancer Treatments and Studies (30 papers). Shoichi Hazama is often cited by papers focused on Cancer Immunotherapy and Biomarkers (34 papers), Immunotherapy and Immune Responses (34 papers) and Colorectal Cancer Treatments and Studies (30 papers). Shoichi Hazama collaborates with scholars based in Japan, United States and Egypt. Shoichi Hazama's co-authors include Masaaki Oka, Shigefumi Yoshino, Yuji Hinoda, Nobuaki Suzuki, Yutaka Suehiro, Kiyoshi Yoshimura, Ryouichi Tsunedomi, Yoshitaro Shindo, Norio Iizuka and Akira Tangoku and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Neuroscience and Biomaterials.

In The Last Decade

Shoichi Hazama

181 papers receiving 4.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shoichi Hazama Japan 40 2.1k 1.7k 1.2k 725 668 187 4.5k
Nelson H. Tsuno Japan 40 1.5k 0.7× 1.7k 1.0× 950 0.8× 784 1.1× 546 0.8× 168 4.7k
Takashi Morisaki Japan 35 1.5k 0.7× 1.4k 0.8× 1.3k 1.1× 693 1.0× 581 0.9× 133 3.7k
Mitsuo Katano Japan 44 2.1k 1.0× 2.9k 1.7× 1.3k 1.1× 1.0k 1.4× 524 0.8× 157 5.5k
Courtney W. Houchen United States 48 2.4k 1.1× 3.0k 1.7× 702 0.6× 1.2k 1.6× 827 1.2× 134 5.9k
Alexander Arlt Germany 42 1.6k 0.7× 2.9k 1.7× 1.2k 1.1× 1.2k 1.6× 804 1.2× 131 5.6k
Lin Zhou China 38 1.2k 0.6× 1.9k 1.1× 868 0.8× 840 1.2× 321 0.5× 149 4.1k
Kazuaki Tanabe Japan 35 1.6k 0.8× 1.8k 1.1× 1.3k 1.1× 542 0.7× 828 1.2× 153 5.2k
Roman A. Blaheta Germany 39 1.0k 0.5× 2.5k 1.4× 723 0.6× 581 0.8× 797 1.2× 208 5.1k
Yoku Hayakawa Japan 41 1.5k 0.7× 1.6k 0.9× 807 0.7× 702 1.0× 1.5k 2.3× 113 4.4k
Yan Li China 31 1.5k 0.7× 1.5k 0.8× 520 0.5× 770 1.1× 976 1.5× 207 4.4k

Countries citing papers authored by Shoichi Hazama

Since Specialization
Citations

This map shows the geographic impact of Shoichi Hazama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shoichi Hazama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shoichi Hazama more than expected).

Fields of papers citing papers by Shoichi Hazama

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shoichi Hazama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shoichi Hazama. The network helps show where Shoichi Hazama may publish in the future.

Co-authorship network of co-authors of Shoichi Hazama

This figure shows the co-authorship network connecting the top 25 collaborators of Shoichi Hazama. A scholar is included among the top collaborators of Shoichi Hazama based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shoichi Hazama. Shoichi Hazama is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Saito, Akira, Koji Fujita, Masaharu Kobayashi, et al.. (2023). Development of multiple AI pipelines that predict neoadjuvant chemotherapy response of breast cancer using H&E‐stained tissues. The Journal of Pathology Clinical Research. 9(3). 182–194. 6 indexed citations
2.
Kimura, Yuta, Ryouichi Tsunedomi, Kiyoshi Yoshimura, et al.. (2022). Immune Evasion of Hepatoma Cancer Stem-Like Cells from Natural Killer Cells. Annals of Surgical Oncology. 29(12). 7423–7433. 8 indexed citations
3.
Shindo, Yoshitaro, et al.. (2019). [Cancer Vaccine Focused on Neoantigens].. PubMed. 46(9). 1367–1371. 2 indexed citations
4.
Tsuji, Shunya, Kazuhiro Yoshimura, Masashi Sakurai, et al.. (2018). Stemness Is Enhanced in Gastric Cancer by a SET/PP2A/E2F1 Axis. Molecular Cancer Research. 16(3). 554–563. 39 indexed citations
5.
Suzuki, Nobuaki, Shinobu Tomochika, Hironori Tanaka, et al.. (2017). [A Case of Conversion Surgery for Unresectable Colorectal Liver Metastases, Following Effective Combined Chemotherapy with Molecular Targeting Agents].. PubMed. 44(12). 1272–1274. 1 indexed citations
6.
7.
Usui, Tatsuya, Masashi Sakurai, Takashi Ohama, et al.. (2016). Establishment of a Novel Model for Anticancer Drug Resistance in Three‐Dimensional Primary Culture of Tumor Microenvironment. Stem Cells International. 2016(1). 7053872–7053872. 42 indexed citations
8.
Yoshino, S., Taku Nishimura, Soichiro Yoshida, et al.. (2016). P-087 A phase II study of a combination treatment of alternate-day S-1 and lentinan as first-line chemotherapy for unresectable or recurrent gastric cancer. Annals of Oncology. 27. ii26–ii26. 2 indexed citations
9.
Tsunedomi, Ryouichi, Shoichi Hazama, Yusuke Fujita, et al.. (2014). A novel system for predicting the toxicity of irinotecan based on statistical pattern recognition with UGT1A genotypes. International Journal of Oncology. 45(4). 1381–1390. 13 indexed citations
10.
Hirata, Keiji, Naoki Nagata, Takeshi Kato, et al.. (2014). Prospective phase II trial of second-line FOLFIRI in patients with advanced colorectal cancer including analysis of UGT1A1 polymorphisms: FLIGHT 2 study.. PubMed. 34(1). 195–201. 9 indexed citations
11.
Maeda, Nobuo, Kiyoshi Yoshimura, Shigeru Yamamoto, et al.. (2014). Expression of B7-H3, a Potential Factor of Tumor Immune Evasion in Combination with the Number of Regulatory T Cells, Affects Against Recurrence-Free Survival in Breast Cancer Patients. Annals of Surgical Oncology. 21(S4). 546–554. 65 indexed citations
12.
Inoue, Yuka, Shoichi Hazama, Shigeyoshi Iwamoto, et al.. (2014). FcγR and EGFR Polymorphisms as Predictive Markers of Cetuximab Efficacy in Metastatic Colorectal Cancer. Molecular Diagnosis & Therapy. 18(5). 541–548. 9 indexed citations
13.
Kanekiyo, Shinsuke, Shoichi Hazama, Hiroshi Kondo, et al.. (2013). UDP-glucuronosyltransferase (UGT) 1A1*28 polymorphism-directed phase II study of irinotecan with 5'-deoxy-5-fluorouridine (5'-DFUR) for metastatic colorectal cancer.. PubMed. 33(8). 3423–30. 6 indexed citations
14.
Shindo, Yoshitaro, Shoichi Hazama, Shinsuke Kanekiyo, et al.. (2013). Intestinal Prolapse Through the Drain Site After Laparoscopy-Assisted Low Anterior Resection: A Case Report. Nihon Gekakei Rengo Gakkaishi (Journal of Japanese College of Surgeons). 38(4). 815–819.
15.
Hazama, Shoichi, Hideyuki Mishima, Ryouichi Tsunedomi, et al.. (2013). UGT1A1*6,1A7*3, and 1A9*22 genotypes predict severe neutropenia in FOLFIRI‐treated metastatic colorectal cancer in two prospective studies in Japan. Cancer Science. 104(12). 1662–1669. 27 indexed citations
16.
Yoshimura, Kiyoshi, Kristen F. Meckel, Christina Y. Chia, et al.. (2009). Integrin α2 Mediates Selective Metastasis to the Liver. Cancer Research. 69(18). 7320–7328. 69 indexed citations
17.
Hashimoto, Kazuo, Yoshihisa Shimizu, Yutaka Suehiro, et al.. (2007). Hypermethylation status of APC inversely correlates with the presence of submucosal invasion in laterally spreading colorectal tumors. Molecular Carcinogenesis. 47(1). 1–8. 10 indexed citations
18.
Tamesa, Takao, Yusaku Watanabe, Kiyoshi Yoshimura, et al.. (2004). [A case of disseminated tumor from cecal cancer with survival for over 5 years after twice surgical resection and systemic chemotherapy].. PubMed. 31(11). 1864–6.
19.
Miyamoto, Koji, Akira Tangoku, Hiroto Hayashi, et al.. (2000). Downregulation of intracellular nm23-H1 prevents cisplatin-induced DNA damage in oesophageal cancer cells: possible association with Na+, K+-ATPase. British Journal of Cancer. 83(9). 1209–1215. 21 indexed citations
20.
Oka, Masaaki, Norio Iizuka, Kohtaro Yamamoto, et al.. (1996). The Influence of Interleukin-6 on the Growth of Human Esophageal Cancer Cell Lines. Journal of Interferon & Cytokine Research. 16(12). 1001–1006. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nelson H. Tsuno Breakdown of academic impact, for papers by Takashi Morisaki Breakdown of academic impact, for papers by Mitsuo Katano Breakdown of academic impact, for papers by Courtney W. Houchen Breakdown of academic impact, for papers by Alexander Arlt Breakdown of academic impact, for papers by Lin Zhou Breakdown of academic impact, for papers by Kazuaki Tanabe Breakdown of academic impact, for papers by Roman A. Blaheta Breakdown of academic impact, for papers by Yoku Hayakawa Breakdown of academic impact, for papers by Yan Li
Rankless by CCL
2026